XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value Assumptions The fair value of the option grants awarded during the nine - month period ended September 30, 2024 was $0.1 million, which has been estimated with the following assumptions on the grant date.
Nine Months Ended September 30
2024
Risk-free interest rate
4.25%-4.61%
Volatility    
106.07% - 123.31%
Expected life (years)    
5.00-6.00
Expected dividend yield    0%
Schedule of Stock Option Activity
The following table summarizes stock option activity for employees and non-employees for the nine months ended September 30, 2024 and 2023:
 SharesWeighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (in years)
Outstanding at December 31, 2022
13,391 $189.36 8.29
Granted— 
Exercised— 
Forfeited— 
Expired— 
Outstanding at September 30, 202313,391 $189.36 7.54
Exercisable at September 30, 20238,893 $226.40 7.36
Outstanding at December 31, 202311,164 $190.24 7.26
Granted21,125 $3.02 
Exercised— 
Forfeited735 
Expired— 
Outstanding at September 30, 202431,554 $66.75 8.45
Exercisable at September 30, 20249,086 $206.48 6.41